Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2003
05/08/2003CA2464944A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003CA2464934A1 Pyrimido [4,5-b] indole derivatives
05/08/2003CA2464924A1 Heteroaromatic carboxamide derivatives for the treatment of inflammation
05/08/2003CA2464727A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464353A1 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003CA2464191A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003CA2464031A1 Purine analogs having hsp90-inhibiting activity
05/08/2003CA2463823A1 Aminobenzamide derivatives as glycogen synthase kinase 3.beta. inhibitors
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463770A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/07/2003EP1308446A1 5-(alkylidene-cycloalkyl)- and 5-(alkylidene-heterocyclyl)-pyrazoles
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308444A1 Substituted 2-(2,6-Dioxo-3-Fluoropiperidine-3-YL)-Isoindolines and their use to reduce TNF-alpha Levels
05/07/2003EP1308440A1 Piperidine derivatives and drugs containing these derivatives as the active ingredient
05/07/2003EP1308161A1 5-N-heterocyclyl-1-(4-sulfonyl-phenyl)-1H-pyrazole derivatives with cyclooxygenase 2 (COX-2) inhibiting activity for the treatment of inflammatory diseases
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line
05/07/2003EP1307557A2 Endothelial cell expression patterns
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307461A2 Substituted pyrrole compounds and their use as spla2 inhibitors
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307208A1 Use of co for treating inflammation of upper airways or bronchi
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1307194A1 Fentanyl composition for nasal administration
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1200106B1 Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
05/07/2003EP1140825B1 Melatonin derivatives and medicine containing same
05/07/2003EP1131326B1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
05/07/2003EP1124544B1 Dry powder pharmaceutical formulation
05/07/2003EP1097698B1 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain
05/07/2003EP1095036B1 Cinnamic acid derivatives as cell adhesion molecules
05/07/2003EP1086079B1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
05/07/2003EP1045822B1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0831893B1 Regulation of neutrophil elastase synthesis and release
05/07/2003EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
05/07/2003EP0749417B1 Cyano compounds and preparations thereof
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003CN1416432A Use of CD25 binding molecules in triatment of inflammatory diseases of gastro-intestinal tract
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416352A Outer membrane vesicle (OMV) vaccine comprising N. Meningitidis serogroup B outer membrane
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1416336A New self emulsifying drug delivery system
05/07/2003CN1416335A New self emulsifying drug delivery system
05/07/2003CN1415375A Ointment of Chinese traditional medicine for curing fever and cough
05/07/2003CN1415366A Tincture for treating boils and its preparation method
05/07/2003CN1415357A Medicament for curing vitro wetness cold illness
05/07/2003CN1415346A Oral liquid for nephrosis
05/07/2003CN1415345A Drug for curing scald, hrut and inflammations as well as hemorrhoids
05/07/2003CN1415342A Decoction of traditional Chinese drug for curing rheumatoid arthritis
05/07/2003CN1415340A Patent Chinese medicine for curing vascular headache
05/07/2003CN1415331A Plaster for releasing ache of periarthritis humeroscapularis and its preparation method
05/07/2003CN1415293A Alkaloid of matrine category utilized for mainline and its preparation method
05/07/2003CN1415290A Diclofenac natrium slowly released capsule and its preparation method
05/07/2003CN1415284A Non-steroid anti-inflammatory drug phospholipid capsule bubble and its preparation method
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107503C Optically pure compoun as medicinal use
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/06/2003US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical
05/06/2003US6559186 Pain is treated topically by administering to the site where sympathetically maintained pain is present an alpha -1-adrenergic antagonist, alpha -2- adrenergic agonist, or other drug that depletes or blocks synthesis of sympathetic
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559160 These compounds and compositions bind to the CXCR3 chemokine receptor and are useful for treating diseases and conditions responsive to the modulation of CXCR3 activity, such as multiple sclerosis, rheumatoid arthritis, psoriasis, cancer,
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559154 Composition of sodium channel blocking compound
05/06/2003US6559142 Tricyclic substituted cyclic sulfonamides compound is useful for treating heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis
05/06/2003US6558692 Over-coated chewing gum formulations
05/06/2003CA2244194C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/06/2003CA2212779C Compositions comprising nanoparticles of nsaid
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/06/2003CA2109208C Radiolabeled metal-binding protein for the treatment of arthritis
05/06/2003CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same
05/06/2003CA2031811C Toxoplasma gondii antigens, the preparation thereof and the use thereof
1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1272